Abstract:Background: Interleukin-21 (IL-21) is involved ill T and NK cell activation and effector response and promotes Th17 cell differentiation. Here we investigated IL-21 receptor (IL-21R) expression ill inflamed mucosa of inflammatory bowel disease (IBD) and evaluated its role in the induction of NK cell cytotoxicity and activation as well as Th17 differentiation.Methods: Expression of IL-21 R was performed by immunohistochemistry and flow cytometry. NK cell cytotoxicity was detected by a standard Cr-51-release assay. Cytokine levels were analyzed by enzyme-linked immunosorbent assay (ELISA) and quantitative real-time polymerase chain reaction (PCR).Results: IL-21R-positive cells were significantly increased in inflamed mucosa of IBD compared with controls, and mainly expressed in freshly isolated peripheral blood (PB)- and lamina propria (LP)-CD4(+), CD8(+) T, B, and NK cells. PB-NK cells from IBD patients produced higher levels of interferon gamma (IFN-gamma) and tumor necrosis factor (TNF) than controls when stimulated with immobilized human IgG and IL-21. IL-21-primed IBD NK cells showed a more potent antitumor cytotoxicity to NK-sensitive K562 cells than controls. Moreover, PB-T and LP-T cells from IBD patients produced large amounts of proinflammatory cytokines (e.g., TNF, IFN-gamma) than controls when stimulated with IL-21 and anti-CD3. Importantly, IL-21 facilitated IBD CD4(+) T cell to differentiate into Th17 cells, characterized by increased expression of IL-17A and ROR gamma t.Conclusions: IL-21 enhances IBD NK cell cytotoxic response. triggers T cells to produce proinflammatory cytokines, and induces IBD CD4(+) T cells to differentiate into Th17 cells, suggesting that IL-21 is involved in the pathogenesis of IBD and that blocking IL-21R signaling may have a therapeutic potential in IBD.

Elevated Levels of Th17 Cells and Th17-Related Cytokines Are Associated with Disease Activity in Patients with Inflammatory Bowel Disease

The Involvement of TH17 Cells in the Pathogenesis of IBD

Interleukin-17 and Inflammatory Bowel Disease: a 2-Sample Mendelian Randomization Study

High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease

Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease

Increased expression of interleukin 17 in inflammatory bowel disease

The Expression of Interleukin-23 Receptor and Interleukin-17a in Patients with Inflammatory Bowel Disease and its Clinical Significance

Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity

TH17 cell: a double-edged sword in the development of inflammatory bowel disease

Th17 cells and colorectal cancer

Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel disease

Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy.

Il-21 Enhances Nk Cell Activation And Cytolytic Activity And Induces Th17 Cell Differentiation In Inflammatory Bowel Disease

Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease

Upregulated IL-17A Secretion and CCR6 Co-Expression in Treg Subsets Are Related to the Imbalance of Treg/Th17 Cells in Active UC Patients

The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer

[Expression of Interleukin 18 in Intestinal Mucosa of Patients with Inflammatory Bowel Disease and Its Implications].

Altered Intestinal Microbiota with Increased Abundance of Prevotella is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome.

Compartmentalized Expression of Th1 and Th17 Cytokines in Pediatric Inflammatory Bowel Diseases

Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93

Elevated Th22 Cells Correlated with Th17 Cells in Patients with Rheumatoid Arthritis